OBJECTIVE: To investigate the relationship between fetal presentation at the time of admission for preterm premature rupture of membranes (PROM) and perinatal outcomes, including gestational latency, among women in a large and well-characterized population with preterm PROM at less than 32 weeks of gestation.
RESULTS:
Of the 1,767 eligible women, 439 (24.5%) had a noncephalic presentation. Noncephalic presentation was associated with an earlier median gestational age at the time of preterm PROM (26.6 compared with 28.4 weeks of gestation, P,.001), but no difference in gestational latency (7.5 compared with 7.7 days, P5.7, adjusted hazard ratio 1.09, 95% confidence interval [CI] 0.97-1.23). There were no differences in odds of abruption or neonatal morbidity in multivariable analyses. However, even after controlling for potential confounding factors including gestational age at delivery and mode of delivery, odds of neonatal death before discharge was greater for noncephalic gestations (11.5% compared with 3.4%, P,.001; adjusted odds ratio 2.24, 95% CI 1.12-4.48).
CONCLUSION: Even after controlling for gestational age and route of delivery, noncephalic fetuses in the setting of preterm PROM are at greater risk of neonatal death.
(Obstet Gynecol 2016;128:812-8) DOI: 10.1097/AOG.0000000000001614 P reterm premature rupture of membranes (PROM), defined as rupture of amniotic membranes before 37 weeks of gestation, complicates approximately 3% of pregnancies. 1 Pregnancies complicated by preterm PROM are at increased risk of placental abruption, intraamniotic infection, cord prolapse, intrauterine fetal demise, sepsis, and endometritis or postpartum infection. 1 Although delivery will occur within 1 week in approximately half of women who experience preterm PROM, a number of factors are thought to influ-ence gestational latency, including gestational age at preterm PROM. [1] [2] [3] Although it is well-established that earlier gestational age is associated with a higher likelihood of a noncephalic presentation of a singleton fetus, 4, 5 it is not well understood whether differences in adverse perinatal outcomes are associated with fetal presentation at the time of membrane rupture.
The limited data that do exist have suggested some differences in maternal and neonatal outcomes based on fetal presentation. A study of 48 women with preterm PROM identified that there was no difference in gestational latency or in composite maternal or neonatal morbidity based on presentation. 6 In contrast, a study of 74 patients identified a higher chance of cord prolapse in pregnancies with a noncephalic presentation as well as a higher frequency of low cord gases or 5-minute Apgar scores, but no statistically significant differences in major neonatal morbidity. 7 A larger report of 566 women with preterm PROM suggested that noncephalic presentation at the time of preterm PROM diagnosis was associated with an increased risk of endometritis, abruption, oligohydramnios, and a maternal composite adverse outcome (ie, abruption, oligohydramnios, or intraamniotic infection). 8 These reports suggest there are conflicting and insufficient data regarding differential outcomes based on presentation at the time of preterm PROM diagnosis.
Thus, the objective of this study was to investigate the relationship between fetal presentation at the time of admission for preterm PROM and perinatal outcomes among women in a large and wellcharacterized population who experienced preterm PROM at less than 32 weeks of gestation. We hypothesized noncephalic presentation in the setting of preterm PROM will be associated with longer gestational latency and increased risk of adverse perinatal outcomes.
MATERIALS AND METHODS
This study is a secondary cohort analysis of a previously reported multicenter randomized clinical trial completed by the Maternal-Fetal Medicine Units Network. The initial study recruited women from 1997 to 2004 at 20 centers. The trial procedures, inclusion criteria, randomization protocol, and data collection process for the original study have been described. 9 Briefly, women were eligible for trial inclusion if they were deemed to be at high risk for preterm delivery between 24 and 31 weeks of gestation as a result of rupture of membranes (22-31 weeks of gestation), spontaneous labor with cervical dilation (4-8 cm), or anticipated indicated iatrogenic preterm delivery (in the next 2-24 hours). 9 Exclusion criteria included hypertension or preeclampsia, recent exposure to magnesium sulfate, delivery expected in less than 2 hours or greater than 8 cm dilation at the time of evaluation, multiple gestation, maternal medical complications contraindicating magnesium treatment, prior study participation, fetal death, known fetal anomaly, or known nonviable fetus. 9 Women were randomized to receive either magnesium or placebo for fetal neuroprotection. All data were edited and validated on a regular basis. Each participating center and the data coordinating center received institutional review board approval before initiation. The present study, using deidentified data, was considered exempt by the institutional review board at Northwestern University. This analysis includes only those women with singleton gestations who were in the study as a result of preterm PROM. The sample size was fixed and based on the total sample for the primary trial. Fetal presentation at the time of randomization was recorded routinely in the original study; randomization occurred proximate to admission for preterm PROM, and thus the fetal presentation is referred to as presentation at the time of admission for preterm PROM. Study groups in the present analysis were defined as cephalic if the fetal head was the presenting part and noncephalic if any other fetal part was presenting (breech or transverse). Perinatal outcomes investigated included abruption, intrauterine fetal demise, 5-minute Apgar score less than 7, neonatal sepsis, neonatal seizures, stage 2 or 3 necrotizing enterocolitis, mechanical ventilation, grade III or IV intraventricular hemorrhage, respiratory distress syndrome, pulmonary hypoplasia, confirmed cerebral palsy, and neonatal death before discharge (death in the neonatal intensive care unit). Definitions for these outcomes were based on the primary study protocol. 9 Perinatal outcomes were then compared for cephalic and noncephalic presentations using x 2 tests, Fisher exact test, and Wilcoxon rank-sum tests for categorical and continuous variables, as appropriate. Logistic regression models were developed to estimate the independent association of noncephalic presentation with perinatal adverse outcomes when adjusting for potential confounders. Linear regression models were created to estimate the independent association of noncephalic presentation with gestational age at preterm PROM and gestational age at delivery. Cox proportional hazards models were performed to estimate the independent association of noncephalic presentation with gestational latency (time from preterm PROM to birth). Given the possibility of interaction between delivery mode and presentation, an interaction term between cesarean delivery and Unauthorized reproduction of this article is prohibited.
cephalic presentation was generated and tested with each perinatal outcome. In addition, an interaction term between postnatally diagnosed major anomalies and noncephalic presentation was generated and tested with the outcome of neonatal death given the potential interaction between fetal anomalies and noncephalic presentation. Finally, given the possibility of relationships between gestational age or fetal anomalies and neonatal death, a post hoc subgroup analysis was performed with a sample matched (one to two) by gestational age at the time of preterm PROM. An additional subgroup analysis assessed neonatal death in the gestational age-matched cohort with exclusion of the neonates with postnatally diagnosed anomalies. Factors with P,.1 in bivariable analysis were included in the regression models. Odds ratios, b coefficients, and hazard ratios, all with 95% confidence intervals, were estimated. All tests were two-tailed and used P,.05 for statistical significance. Stata 13.0 was used for all analyses.
RESULTS
For this analysis, 1,767 women met inclusion criteria, of whom 439 (24.5%) had noncephalic presentations. There were few clinically significant demographic differences between women with cephalic and noncephalic presentation (Table 1) . Women with noncephalic presentations were slightly older and had slightly higher body mass indexes than women with cephalic presentation. Women with noncephalic presenting fetuses were more likely to be married (55.3% compared with 45.6%, P5.001), less likely to be nulliparous (27.8% compared with 36.3%, P5.001), and less likely to have engaged in illicit drug use during pregnancy (7.1% compared with 11.5%, P5.009) than women with cephalic presentation. Women with noncephalic presentation also had a higher likelihood of second-or third-trimester bleeding (20.7% compared with 11.9%, P,.001) and a higher likelihood of fetal anomalies (5.5% compared with 2.9%, P5.01). Notably, anomalies were diagnosed postnatally, because known fetal anomalies were cause for exclusion from the Beneficial Effects of Antenatal Magnesium Sulfate (1997-2004) trial. Birth weights for noncephalic presenting gestations were lower (1,247 compared with 1,514 g, P,.001) than women with cephalic presentations, consistent with their earlier gestational age at delivery. There were no differences in proportion of male neonates, proportion randomized to magnesium treatment, or rates of chorioamnionitis between the cephalic and noncephalic groups. Women with noncephalic presentation experienced preterm PROM at an earlier gestational age than women with a cephalic presentation ( Table 2) . The median gestational age of preterm PROM for women with a noncephalic presentation was 26.6 weeks compared with 28.4 weeks for cephalic presentation (P,.001). Median gestational age at birth also was earlier for women with noncephalic presentations (28.6 compared with 30.4 weeks, P,.001). After adjusting for maternal age, body mass index, race and ethnicity, prenatal care, marital status, parity, drug use, second-or third-trimester bleeding, and major anomalies, the gestational ages at time of preterm PROM and at birth remained statistically significantly earlier for women with noncephalic presentations. However, the median latency was not different for women with noncephalic presentations compared with those with cephalic presentation (7.5 compared with 7.7 days, P5.7; adjusted hazard ratio 1.09, 95% (Table 3 ). No differences in risk of abruption, intrauterine fetal demise, necrotizing enterocolitis, grade III or IV intraventricular hemorrhage, or pulmonary hypoplasia were identified. Although women who had noncephalic presenting fetuses had a higher frequency of 5-minute Apgar score less than 7, neonatal sepsis, neonatal seizures, mechanical ventilation, respiratory distress syndrome, and definite cerebral palsy on bivariable analyses, none of these associations remained statistically significant after accounting for potential confounders, including gestational age and delivery mode. Conversely, neonatal death before discharge was more frequent among neonates with a noncephalic presentation (11.5% compared with 3.4%, P,.001) at preterm PROM, and this association remained statistically significant in the multivariable logistic regression model (adjusted odds ratio [OR] 2.24, 95% CI 1.12-4.48). These findings were unchanged when the regression model accounted for gestational age at the time of enrollment rather than gestational age at the time of delivery. Of note, there was no significant interaction between mode of delivery and fetal presentation with regard to the outcome of neonatal death. Data are n (%) or adjusted odds ratio* (95% confidence interval). * Compared with cephalic presentation. Adjusted for maternal age, body mass index, race and ethnicity, prenatal care, marital status, parity, drug use, second-or third-trimester bleeding, major anomalies, gestational age at birth, and delivery mode. Regression analyses for abruption and intrauterine fetal demise are not adjusted for mode of delivery.
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Given the results identified here, we investigated whether the relationship between fetal position and neonatal death was driven by fetal anomalies. Although there was an increased frequency of neonatal death among anomalous neonates compared with nonanomalous neonates (24.6% compared with 4.7%, P,.001), entry of an interaction term between anomalies and noncephalic presentation into the regression analysis for neonatal death demonstrated there was no significant interaction (adjusted OR 1.64, 95% CI 0.32-8.31) with regard to this outcome. In this regression model, there remained an independent association between noncephalic presentation and neonatal death (adjusted OR 2.11, 95% CI 1.03-4.33) and between anomalies and neonatal death (adjusted OR 7.15, 95% CI 2.15-23.77). These findings indicate that although both noncephalic presentation and anomalies were independently associated with death, the magnitude of association between noncephalic presentation and neonatal death did not differ based on whether an anomaly was present.
Finally, to confirm that the relationship between noncephalic presentation and neonatal death was not the result of gestational age or anomalies, we performed a subgroup analysis with a cohort matched by gestational age at the time of preterm PROM. In this analysis, we matched 431 women with noncephalic presentation to 862 women with cephalic presentation within 1 week of the gestational age at rupture of membranes (demographic and clinical characteristics of the matched subgroup are shown in Table 4 ). The mean gestational age at rupture of membranes of this sample was 26.8 weeks (standard deviation 2.4). In this matched subgroup, there remained an increased odds of death among the noncephalic neonates (11.2% compared with 4.8%, P,.001; adjusted OR 3.15, 95% CI 1.62-6.13) when accounting for potential confounders with P,.1 on bivariable analyses. In this subgroup, the outcomes of analyses with the described interaction factors were unchanged, and the relationship between death and anomalies persisted (adjusted OR 3.90, 95% CI 1.84-8.23). When performing an additional subgroup analysis eliminating those with anomalies from this matched cohort (demographic and clinical characteristics shown in Table 5 ), there remained an independent association between noncephalic presentation and death (10.1% compared with 4.4%, P,.001; adjusted OR 2.82, 95% CI 1.46-5.48) when accounting for potential confounders with P,.1 on bivariable analyses.
DISCUSSION
The intent of this secondary analysis of a large and diverse cohort of women with preterm PROM at less than 32 weeks of gestation was to evaluate whether fetal presentation at the time of admission for preterm PROM was associated with adverse perinatal outcomes. These data suggest that fetuses with a noncephalic presentation at admission for preterm PROM were at significantly increased risk of death before discharge compared with those with cephalic presentation, even after controlling for factors such as gestational age and mode of delivery. In addition, although those with noncephalic presentations were more likely to experience preterm PROM at an earlier gestational age and subsequently deliver at an earlier gestational age, we did not identify any difference in gestational latency based on fetal presentation. The finding that there was no statistically significant difference in latency based on fetal presentation may aid health care providers with both counseling and pregnancy monitoring in the setting of preterm PROM. Although there is a known increased risk of placental abruption in the setting of preterm PROM, 10 in contrast to prior reports, we did not identify differences in the likelihood of abruption based on fetal presentation, yet we did note that women with a noncephalic presentation had a greater likelihood of experiencing second-or third-trimester bleeding, which is potentially associated with the earlier gestational age at preterm PROM. Prior work has suggested that the increased risk of abruption associated with noncephalic presentation does not remain statistically significant if analyzing only those women who had a latency period of greater than 1 day, which suggests this differential risk of abruption may not be the result of fetal presentation but rather the confounding factors that are associated with delivery within 24 hours of preterm PROM. 8 Moreover, our data do not identify statistically significant associations between neonatal morbidity and fetal presentation, which is a finding consistent with that of Goodman et al. 8 It should be noted, however, that the study lacked power to identify differences in rare neonatal adverse events.
However, we did identify an increased risk for neonatal death before hospital discharge among neonates who had noncephalic presentations. The reason why these neonates were more likely to experience death remains uncertain, because the data lacked granularity about specific causes of death and the study was not powered to investigate differences in cause of death. However, it does not appear to be related to the possible complications associated with breech vaginal delivery nor does it appear to be solely related to anomalies, because these possibilities were accounted for in regression analysis. Although anomalies were associated with neonatal death, noncephalic presentation additionally remained independently associated with neonatal death. Moreover, in a gestational age-matched subgroup analysis eliminating cases with postnatally diagnosed anomalies, this relationship persisted. Thus, anomalies do not fully explain the relationship between noncephalic presentation and neonatal death. One potential explanation is that differences in neonatal morbidity identified on bivariable analysis such as sepsis may have contributed to the differences in death, but were not identified as a result of lack of power to assess differences in rare neonatal events. Additional prospective investigation is required to better understand the potential mechanisms behind this identified risk of death.
Strengths of this study are that it is a large, diverse cohort that was well characterized and had clear clinical definitions for each prospectively collected outcome measure. Preterm PROM was confirmed using a standard protocol, and pregnancies included in the study had reliable dating. The size of the study allowed for comparisons with less chance of type II error than in prior work as a result of smaller sample sizes. In addition, participants in this study received care in a large number of hospitals in different regions and with varying practice patterns, suggesting these data are generalizable. The inclusion of postnatally diagnosed fetal anomalies also contributes to generalizability, because any woman without a known fetal anomaly may still experience a fetal anomaly.
However, there are several limitations to consider. This study included women with preterm PROM before 32 weeks of gestation, and thus data Unauthorized reproduction of this article is prohibited.
may not be generalizable to patients with preterm PROM presenting beyond 32 weeks of gestation. Importantly, although we identified an association between noncephalic presentation and mortality, it is not possible to determine a causal relationship, and it is possible that other factors such as uterine abnormalities could have contributed to the findings. Furthermore, study groups were based on fetal presentation at the time of randomization rather than presentation at the time of delivery, because data on presentation at time of delivery were not available; however, because the evidence suggests that spontaneous version after preterm PROM is rare, 11 and because counseling should occur at the time of presentation with preterm PROM and not be delayed until delivery, we do not believe this issue limits clinical applicability. Furthermore, abruption in the Beneficial Effects of Antenatal Magnesium Sulfate trial was based on clinical suspicion rather than placental pathologic evaluation; it is possible that alternative criteria for the diagnosis of abruption would yield different results. Additionally, it is possible that residual confounding may occur from variables that were unmeasured; notably, this was an unplanned secondary analysis of the Beneficial Effects of Antenatal Magnesium Sulfate trial, and thus not all data relevant to this study question were available for this analysis. Finally, it is important to note that that we were underpowered to detect relatively small differences in rare outcomes. The lack of relationship between fetal presentation and adverse neonatal outcomes aside from death may be the result of lack of statistical power to detect differences in rare events rather than a true absence of an association.
In summary, in this large and well-characterized population, women with noncephalic presentation at the time of admission for preterm PROM did not experience any difference in gestational latency or in the majority of neonatal adverse outcomes, although ability to examine differences in rare neonatal morbidities was limited. However, neonates with a noncephalic presentation at admission for preterm PROM were at increased risk of death before discharge for reasons that cannot be well elucidated by this analysis. These findings may have utility in the counseling and observation of women experiencing preterm PROM.
